Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: Results of a phase III randomized trial

Journal of Clinical Oncology

Volumn 30, Issue 15, 2012, Pages 1777-1783

  Janssens, Geert O ^a   Rademakers, Saskia E ^a   Terhaard, Chris H ^b   Doornaert, Patricia A ^c   Bijl, Hendrik P ^d   Van Ende, Piet Den ^e   Chin, Alim ^f   Marres, Henri A ^a   De Bree, Remco ^c   Van Der Kogel, Albert J ^a   Hoogsteen, Ilse J ^a   Bussink, Johannes ^a   Span, Paul N ^a   Kaanders, Johannes H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; NICOTINAMIDE; PIMONIDAZOLE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OVERALL SURVIVAL; OXYGENATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SEPSIS; STOMACH HEMORRHAGE; TUMOR BIOPSY; UPPER RESPIRATORY TRACT OBSTRUCTION;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CARBON DIOXIDE; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; GREAT BRITAIN; HUMANS; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; NIACINAMIDE; OXYGEN; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RADIATION-SENSITIZING AGENTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VITAMIN B COMPLEX;

EID: 84864003904     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.35.9315     Document Type: Article

References (37)

1. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery with radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
2. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003 (Pubitemid 37464533)
3. Kaanders JH, Bussink J, van der Kogel AJ: ARCON: A novel biology-based approach in radio-therapy. Lancet Oncol 12:728-837, 2002
4. Fu KK, Pajak TF, Trotti A, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16, 2000 (Pubitemid 30488207)
5. Overgaard J, Hansen HS, Specht L, et al: Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362:933-940, 2003 (Pubitemid 37159288)
6. Bourhis J, Overgaard J, Audry H, et al: Hyper-fractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. Lancet 368:843-854, 2006 (Pubitemid 44292807)
7. Chaplin DJ, Horsman MR, Trotter MJ: The effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J Natl Cancer Inst 82:672-676, 1990 (Pubitemid 20154274)
8. Horsman MR, Chaplin DJ, Overgaard J: Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells. Cancer Res 50:7430-7436, 1990
9. Martin L, Lartigau E, Weeger P, et al: Changes in oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol 27:123-130, 1993 (Pubitemid 23192641)
10. Bussink J, Kaanders JH, Rijken PF, et al: Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: Effects of carbogen and nicotinamide. Radiother Oncol 50:173-184, 1999 (Pubitemid 29155543)
11. Bussink J, Kaanders JH, Strik AM, et al: Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescence based fiber-optic probes. Radiother Oncol 57:21-30, 2000
12. Rojas A, Hirst VK, Calvert AS, et al: Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy. Int J Radiat Oncol Biol Phys 34:357-365, 1996 (Pubitemid 26031580)
13. Kaanders JH, Pop LA, Marres HA, et al: Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: Feasibility and toxicity. Radiother Oncol 37:190-198, 1995 (Pubitemid 26007661)
14. Kaanders JH, Pop LA, Marres HA, et al: ARCON: Experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 52:769-778, 2002 (Pubitemid 34158740)
15. Kaanders JH, Stratford MR, Liefers J, et al: Administration of nicotinamide during a five to seven-week course of radiotherapy: Pharmacokinetics, tolerance, and compliance. Radiother Oncol 43:67-73, 1997 (Pubitemid 27191981)
16. Janssens GO, Terhaard CH, Doornaert PA, et al: Acute toxicity profile and compliance to ARCON for clinical stage T2-4 laryngeal cancer: results of a phase III randomized trial. Int J Rad Oncol Biol Phys 82:532-538, 2012
17. Kaanders JH, Wijffels KI, Marres HA, et al: Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62:7066-7074, 2002 (Pubitemid 35424102)
18. Robbins KT, Medina JE, Wolfe GT, et al: Standardizing neck dissection terminology: Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 117:601-605, 1991
19. International Commission on Radiation Units and Measurements: Prescribing, Recording, and Reporting Photon Beam Therapy. Report 50. Bethesda, MD, ICRU Publications, 1992
20. Henk JM, Kunkler PB, Smith CW: Radiotherapy and hyperbaric oxygen in head and neck cancer: Final report of first controlled clinical trial. Lancet 2:101-103, 1997
21. Haustermans K, van der Kogel AJ, Vanacker B, et al: Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance. Radiother Oncol 31:123-128, 1994 (Pubitemid 24189087)
22. Dische S, Rojas A, Rugg T, et al: Carbogen breathing: A system for use in man. Br J Radiol 65:87-90, 1992
23. Kaanders JH, van der Maazen RW: A convenient and reliable method for carbogen breathing in man. Radiother Oncol 29:341-343, 1993 (Pubitemid 24025356)
24. Hoogsteen IJ, Lok J, Marres HA, et al: Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia. Eur J Cancer 45:2906-2914, 2009
25. Nakfoor BM, Spiro IJ, Wang CC, et al: Results of accelerated radiotherapy for supraglottic carcinoma: A Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience. Head Neck 20:379-384, 1998
26. Mendenhall WM, Parsons JT, Mancuso AA, et al: Radiotherapy for squamous cell carcinoma of the supraglottic larynx: An alternative to surgery. Head Neck 18:24-35, 1996 (Pubitemid 26002034)
27. Garden AS, Forster K, Wong PF, et al: Results of radiotherapy for T2N0 glottic carcinoma: Does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 55:322-328, 2003 (Pubitemid 36069089)
28. Hinerman RW, Mendenhall WM, Amdur RJ, et al: Carcinoma of the supraglottic larynx: Treatment results with radiotherapy alone or with planned neck dissection. Head Neck 24:456-467, 2002 (Pubitemid 34506706)
29. Fletcher GH, Lindberg RD, Jesse RH: Radiation therapy for cancer of the larynx and pyriform sinus. Eye Ear Nose Throat Digest 31:58-67, 1969
30. Wang CC, Montgomery WW: Deciding on optimal management of supraglottic carcinoma. Oncology 5:41-46, 1991
31. Ghossein NA, Bataini JP, Ennuyer A, et al: Local control and site of failure in radically irradiated supraglottic laryngeal cancer. Radiology 112:187-192, 1974
32. Bentzen SM: Dose-response relationships in radiotherapy, in Joiner M, van der Kogel A (eds): Textbook Basic Clinical Radiobiology. London, United Kingdom, Hodder Arnold, 2009, pp 60-63
33. Overgaard J: Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. Radiother Oncol 100:22-32, 2011
34. Machtay M, Moughan J, Trotti A, et al: Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol 26:3582-3589, 2008
35. Hoskin PJ, Rojas AM, Saunders MI, et al: Carbogen and nicotinamide in locally advanced bladder cancer: Early results of a phase-III randomized trial. Radiother Oncol 91:120-125, 2009
36. Hoskin PJ, Rojas AM, Bentzen SM, et al: Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma. J Clin Oncol 28:4912-4918, 2010
37. Overgaard J: Hypoxic radiosensitization: Adored and ignored. J Clin Oncol 25:4066-4074, 2007